A systematic review and meta‐analysis of new‐onset atrial fibrillation in the context of COVID‐19 infection
- 7 January 2024
- journal article
- review article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (3) , 478-487
Abstract
New‐onset atrial fibrillation (NOAF) in COVID‐19 raises significant clinical and public health issues. This systematic review and meta‐analysis aims to compile and analyze the current literature on NOAF in COVID‐19 and give a more comprehensive understanding of the prevalence and outcomes of NOAF in COVID‐19. A comprehensive literature search was carried out using several databases. The random effect model using inverse variance method and DerSimonian and Laird estimator of Tua2 was used to calculate the pooled prevalence and associated 95% confidence interval (CI). Results for outcome analysis were presented as odds ratios (ORs) with 95% CI and pooled using the Mantel‐Haenszel random‐effects model. The pooled prevalence of NOAF in COVID‐19 was 7.8% (95% CI: 6.54%–9.32%),a pooled estimate from 30 articles (81 929 COVID‐19 patients). Furthermore, our analysis reported that COVID‐19 patients with NOAF had a higher risk of developing severe disease compared with COVID‐19 patients without a history of atrial fibrillation (OR = 4.78, 95% CI: 3.75–6.09) and COVID‐19 patients with a history of pre‐existing atrial fibrillation (OR = 2.75, 95% CI: 2.10–3.59). Similarly, our analysis also indicated that COVID‐19 patients with NOAF had a higher risk of all‐cause mortality compared with, COVID‐19 patients without a history of atrial fibrillation (OR = 3.83, 95% CI: 2.99–4.92) and COVID‐19 patients with a history of pre‐existing atrial fibrillation (OR = 2.32, 95% CI: 1.35–3.96). The meta‐analysis did not reveal any significant publication bias. The results indicate a strong correlation between NOAF and a higher risk of severe illness and mortality. These results emphasize the importance of careful surveillance, early detection, and customized NOAF management strategies to improve clinical outcomes for COVID‐19 patients.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Cardiac Arrhythmias in Critically Ill Patients With COVID-19: A Brief ReviewJournal of Cardiothoracic and Vascular Anesthesia, 2021
- Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infectionHeart Rhythm, 2021
- New-onset atrial fibrillation during COVID-19 infection predicts poor prognosisCardiology Journal, 2021
- Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19Circulation: Arrhythmia and Electrophysiology, 2021
- Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19Journal of Clinical Medicine, 2021
- Cardiac inflammation in COVID-19: Lessons from heart failureLife Sciences, 2020
- COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implicationsIJC Heart & Vasculature, 2020
- Clinical characteristics and prognosis of hospitalized COVID‐19 patients with incident sustained tachyarrhythmias: A multicenter observational studyEuropean Journal of Clinical Investigation, 2020
- New-onset atrial fibrillation in adult critically ill patients: a scoping reviewIntensive Care Medicine, 2019
- Atrial Remodeling and Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2008